Related Experiment Video
Updated: May 14, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials
Dennis A K Rice1, Koné Kaniga, Michael Lee
1Janssen Medical Affairs, Raritan, NJ, USA. drice2@its.jnj.com
Abstract:
An analysis of subjects with concurrent bacteraemia and either nosocomial pneumonia, complicated intra-abdominal infection or complicated urinary tract infection from six phase 3 clinical trials demonstrated similar cure rates and clearance of bacteraemia in patients treated with doripenem and comparator agents.
Related Concept Videos
Antimicrobial Effectiveness
Acute Pyelonephritis II: Diagnostic Studies and Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Significance of Antibiotic Resistance
Clinical Trials: Overview
